Constitution Capital LLC Has $3.39 Million Holdings in UnitedHealth Group Incorporated $UNH

Constitution Capital LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 46.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 9,827 shares of the healthcare conglomerate’s stock after buying an additional 3,125 shares during the quarter. UnitedHealth Group makes up about 1.6% of Constitution Capital LLC’s holdings, making the stock its 19th largest holding. Constitution Capital LLC’s holdings in UnitedHealth Group were worth $3,393,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. LFA Lugano Financial Advisors SA acquired a new stake in shares of UnitedHealth Group in the second quarter worth $25,000. Bayforest Capital Ltd boosted its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the period. Sagard Holdings Management Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $29,000. Islay Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the second quarter worth approximately $31,000. Finally, Riggs Asset Managment Co. Inc. increased its stake in UnitedHealth Group by 69.4% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 43 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.3%

UNH stock opened at $331.76 on Monday. The company has a market cap of $300.52 billion, a PE ratio of 17.32, a price-to-earnings-growth ratio of 2.16 and a beta of 0.43. The business’s 50-day simple moving average is $333.71 and its 200 day simple moving average is $319.16. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter last year, the company earned $7.15 earnings per share. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on UNH. Barclays boosted their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a research note on Wednesday, October 29th. Royal Bank Of Canada increased their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. The Goldman Sachs Group began coverage on UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 target price for the company. Finally, JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.